Holen Sie sich die Stockscreener-App
29.50
1.60%
-0.49
Finanzdaten der Dyne Therapeutics Inc-Aktie (DYN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
2.17%
69.16
|
67.69 | 62.27 | 66.74 | 45.46 |
| Operating Income/Loss |
2.17%
-69.16
|
-67.69 | -62.27 | -66.74 | -45.46 |
| Income/Loss From Continuing Operations Before Tax |
1.48%
-65.65
|
-66.64 | -60.21 | -64.90 | -44.19 |
| Income/Loss From Continuing Operations After Tax |
1.48%
-65.65
|
-66.64 | -60.21 | -64.90 | -44.19 |
|
Net Income/Loss
|
1.48%
-65.65
|
-66.64 | -60.21 | -64.90 | -44.19 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Earnings Per Share |
25.69%
-0.81
|
-1.09 | -0.99 | -1.08 | -0.78 |
| Diluted Earnings Per Share |
25.69%
-0.81
|
-1.09 | -0.99 | -1.08 | -0.78 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):